Chapter 8021： The future of Xuanji Medicine

At the same time, Liu Qinghe's move can be regarded as a fierce battle for the Chinese medical community.

Most importantly, this is also a good foundation for Zhang Xiaofan to win the next Nobel Prize in Medicine.

As for Liu Qinghe, he only needs to explain at the international exchange seminar that all these remarks and research results are based on Zhang Xiaofan's theoretical formulas.

So there is no doubt that this will bring unprecedented sensational effects to the entire medical world.

After hearing this, Zhang Xiaofan felt that there were some feelings of crying and laughing.

Unexpectedly, an old scholar like Liu Qinghe was still working hard for his Nobel Medical Prize.

Last time Liu Qinghe talked to himself about the Nobel Medical Prize, Zhang Xiaofan had already politely refused it, showing that he really does not care about the fame and fortune of these secular worlds.

But afterwards, seeing Liu Qinghe was so attentive about running for the next Nobel Medical Prize for himself, and after being so concerned, Zhang Xiaofan did not take it too seriously.

At the same time, he did not refuse Liu Qinghe's kindness to himself, let Liu Qing and himself look at it and prepare.

After Liu Qinghe left Xuanji Group, the research and development of new drugs and the press conference were temporarily postponed.

For some of the core and most critical secrets of the Xuanji Pharmaceutical Group at the moment, only Zhang Xiaofan can do so.

In particular, after designing the Xuanji Pharmaceutical Group to develop into today's foundation of safety and survival, the 'silver bullet' anticancer drug is not as simple as it appears on the surface.

Because, the key base medicine for making the "silver bullet" anti-cancer drug can be found all over the world, and it can only be found in the function of Miaojiang. Baihuaguzhongfan under the jurisdiction of Zhang Xiaofan.

In addition to the issue of the important raw material of ‘Silver Bullet’, the smooth production of the ‘Silver Bullet’ anti-cancer drug needs to be completed. The threshold for refining medicine technology lies here.

In the face of so many technical barriers of "silver bullets", and the monopoly of pharmaceutical raw materials, this means that even if 10,000 steps back, Liu Qinghe really decided to resign and leave.

Unless, he took away all the raw materials and brains of Miaojiang Baihua Valley that can produce silver bullet anticancer drugs, as well as further mastering the knowledge of refining medicine in the realm.

Then, Liu Qinghe could only develop a silver bullet anticancer drug.

If not, it is absolutely impossible to imitate the "silver bullet" anticancer drug based on the overall development level of Liu Qinghe and the present-day Chinese medical community.

As for the special drugs developed by Liu Qinghe, they are responsible for occupying some products in the mid-end pharmaceutical market.

If a competing company can obtain the prescriptions of these special effects drugs through commercial spies, there is still a high probability that they can be imitated and copied.

But still that sentence, as long as Xuanji Pharmaceutical Group has mastered the core technology, that is to say, the silver bullet, it will already be invincible.

As for the release of new special effects medicine products of other Xuanji Pharmaceutical Group.

For a large group such as Xuanji Pharmaceutical Group, the role that large enterprises can play is nothing but the icing on the cake, which can further improve the group's product line.